MOACM
ENTA icon

Mutual of America Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Mutual of America Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,875
Closed -$201K – 1493
2022
Q3 		$201K Buy
3,875
+780
+25% +$45.6K ﹤0.01% 1361
2022
Q2 		$146K Buy
3,095
+466
+18% +$25.3K ﹤0.01% 1417
2022
Q1 		$187K Buy
2,629
+170
+7% +$11.1K ﹤0.01% 1371
2021
Q4 		$184K Buy
2,459
+60
+3% +$4.71K ﹤0.01% 1369
2021
Q3 		$136K Sell
2,399
-157
-6% -$7.76K ﹤0.01% 1451
2021
Q2 		$112K Buy
2,556
+158
+7% +$7.74K ﹤0.01% 1541
2021
Q1 		$118K Buy
2,398
+166
+7% +$8.28K ﹤0.01% 1495
2020
Q4 		$94K Buy
2,232
+78
+4% +$3.43K ﹤0.01% 1493
2020
Q3 		$99K Buy
2,154
+1,359
+171% +$65.8K ﹤0.01% 1401
2020
Q2 		$40K Buy
795
+97
+14% +$5.02K ﹤0.01% 1401
2020
Q1 		$36K Buy
698
+132
+23% +$7.04K ﹤0.01% 1355
2019
Q4 		$35K Sell
566
-29
-5% -$1.8K ﹤0.01% 1439
2019
Q3 		$36K Buy
595
+23
+4% +$1.71K ﹤0.01% 1427
2019
Q2 		$48K Buy
572
+122
+27% +$11K ﹤0.01% 1342
2019
Q1 		$43K Buy
450
+60
+15% +$5.38K ﹤0.01% 1328
2018
Q4 		$28K Buy
390
+91
+30% +$6.98K ﹤0.01% 1385
2018
Q3 		$26K Buy
299
+246
+464% +$24.6K ﹤0.01% 1412
2018
Q2 		$6K Buy
+53
New +$5.29K ﹤0.01% 1336

Other funds holding ENTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Mutual of America Capital Management's ENTA Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q4 2022, closing a stake of 3,875 shares — an estimated $201K sold.

Mutual of America Capital Management first reported a position in ENTA in Q2 2018 and held it in 18 quarters. The position peaked at $201K in Q3 2022. 147 funds tracked by Wall St. Rank hold ENTA as of Q4 2022.

  • Mutual of America Capital Management reported no remaining Enanta Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 3,875 Enanta Pharmaceuticals shares in Q4 2022, an estimated $201K.
  • Mutual of America Capital Management first reported a position in Enanta Pharmaceuticals in Q2 2018 and held it in 18 quarters.
  • Mutual of America Capital Management's Enanta Pharmaceuticals position peaked at $201K in Q3 2022.
  • 147 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.